Pulmonary hyperinflation and left ventricular mass: The multi-ethnic study of atherosclerosis COPD study

Circulation

Volumn 127, Issue 14, 2013, Pages 1503-1511

  Smith, Benjamin M ^a,b   Kawut, Steven M ^c   Bluemke, David A ^d   Basner, Robert C ^a   Gomes, Antoinette S ^e   Hoffman, Eric ^f   Kalhan, Ravi ^g   Lima, João A C ^h   Liu, Chia Ying ^h   Michos, Erin D ^h   Prince, Martin R ^a   Rabbani, Leroy ^a   Rabinowitz, Daniel ⁱ   Shimbo, Daichi ^a   Shea, Steven ^a,i   Barr, R Graham ^a,i  

^a Columbia University ^*  (United States)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF IOWA   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ NONE   (United States)

Author keywords

Chronic obstructive pulmonary disease; Hyperinflation; Left ventricular mass

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY PLETHYSMOGRAPHY; BODY SIZE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTED TOMOGRAPHY SCANNER; DIAGNOSTIC KIT; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE MASS; HUMAN; HYPERINFLATION; LUNG FUNCTION TEST; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RESIDUAL VOLUME; SENSITIVITY ANALYSIS; SMOKING; SPHYGMOMANOMETER; SPIROMETER; SYSTOLIC BLOOD PRESSURE; TOTAL LUNG CAPACITY;

AGED; ATHEROSCLEROSIS; EMPHYSEMA; FEMALE; HEART FAILURE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PLETHYSMOGRAPHY; PREDICTIVE VALUE OF TESTS; PRESSURE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESIDUAL VOLUME; RISK FACTORS; SMOKING; TOMOGRAPHY, X-RAY COMPUTED; TOTAL LUNG CAPACITY;

EID: 84876153674     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.001653     Document Type: Article

References (60)

1. Minino AM, Murphy SL. Deaths in the United States. NCHS Data Brief. 2012:1-8.
2. Iversen KK, Kjaergaard J, Akkan D, Kober L, Torp-Pedersen C, Hassager C, Vestbo J, Kjoller E; ECHOS-Lung Function Study Group. Chronic obstructive pulmonary disease in patients admitted with heart failure. J Intern Med. 2008;264:361-369.
3. Rutten FH, Cramer MJ, Grobbee DE, Sachs AP, Kirkels JH, Lammers JW, Hoes AW. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J. 2005;26:1887-1894. (Pubitemid 41253302)
4. Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR, Goehring E Jr, She D. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan, Canada: cardiovascular disease in COPD patients. Ann Epidemiol. 2006;16:63-70. (Pubitemid 41783891)
5. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561-1566. (Pubitemid 20176696)
6. Haider AW, Larson MG, Benjamin EJ, Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol. 1998;32:1454-1459. (Pubitemid 28522409)
7. Bluemke DA, Kronmal RA, Lima JA, Liu K, Olson J, Burke GL, Folsom AR. The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol. 2008;52:2148-2155.
8. Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahlöf B; LIFE Study Investigators. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA. 2004;292:2343-2349. (Pubitemid 39491918)
9. Okin PM, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Julius S, Edelman JM, Dahlöf B; LIFE Study Investigators. Regression of elec-trocardiographic left ventricular hypertrophy is associated with less hos-pitalization for heart failure in hypertensive patients. Ann Intern Med. 2007;147:311-319. (Pubitemid 351664558)
10. Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris K, Aurup P, Dahlöf B. Prognostic signifcance of left ventricular mass change during treatment of hypertension. JAMA. 2004;292:2350-2356. (Pubitemid 39491919)
11. Baum GL, Schwartz A, Llamas R, Castillo C. Left ventricular function in chronic obstructive lung disease. N Engl J Med. 1971;285:361-365.
12. Kohama A, Tanouchi J, Hori M, Kitabatake A, Kamada T. Pathologic involvement of the left ventricle in chronic cor pulmonale. Chest. 1990;98:794-800. (Pubitemid 20355479)
13. Fluck DC, Chandrasekar RG, Gardner FV. Left ventricular hypertrophy in chronic bronchitis. Br Heart J. 1966;28:92-97.
14. Scott KW. A clinicopathological study of fatal chronic airways obstruction. Thorax. 1976;31:693-701. (Pubitemid 8014996)
15. Vonk-Noordegraaf A, Marcus JT, Holverda S, Roseboom B, Postmus PE. Early changes of cardiac structure and function in COPD patients with mild hypoxemia. Chest. 2005;127:1898-1903.
16. Jörgensen K, Müller MF, Nel J, Upton RN, Houltz E, Ricksten SE. Reduced intrathoracic blood volume and left and right ventricular dimensions in patients with severe emphysema: an MRI study. Chest. 2007;131:1050-1057. (Pubitemid 46608706)
17. Funk GC, Lang I, Schenk P, Valipour A, Hartl S, Burghuber OC. Left ventricular diastolic dysfunction in patients with COPD in the presence and absence of elevated pulmonary arterial pressure. Chest. 2008;133:1354-1359. (Pubitemid 351892990)
18. Anderson WJ, Lipworth BJ, Rekhraj S, Struthers AD, George J. Left ventricular hypertrophy in COPD without hypoxemia: the elephant in the room? Chest. 2013;143:91-97.
19. Leith DE, Brown R. Human lung volumes and the mechanisms that set them. Eur Respir J. 1999;13:468-472. (Pubitemid 29086854)
20. Timmins SC, Diba C, Farrow CE, Schoeffel RE, Berend N, Salome CM, King GG. The relationship between airfow obstruction, emphysema extent, and small airways function in COPD. Chest. 2012;142:312-319.
21. Sciurba FC. Physiologic similarities and differences between COPD and asthma. Chest. 2004;126(suppl):117S-124S. (Pubitemid 39093401)
22. Potter WA, Olafsson S, Hyatt RE. Ventilatory mechanics and expiratory fow limitation during exercise in patients with obstructive lung disease. J Clin Invest. 1971;50:910-919.
23. O'Connell JM, Campbell AH. Respiratory mechanics in airways obstruction associated with inspiratory dyspnoea. Thorax. 1976;31:669-677. (Pubitemid 8014993)
24. Montes de Oca M, Rassulo J, Celli BR. Respiratory muscle and cardiopul-monary function during exercise in very severe COPD. Am J Respir Crit Care Med. 1996;154:1284-1289. (Pubitemid 26391170)
25. Laveneziana P, Webb KA, Ora J, Wadell K, O'Donnell DE. Evolution of dyspnea during exercise in chronic obstructive pulmonary disease: impact of critical volume constraints. Am J Respir Crit Care Med. 2011;184:1367-1373.
26. Stalcup SA, Mellins RB. Mechanical forces producing pulmonary edema in acute asthma. N Engl J Med. 1977;297:592-596. (Pubitemid 8197340)
27. Robotham JL, Lixfeld W, Holland L, MacGregor D, Bryan AC, Rabson J. Effects of respiration on cardiac performance. J Appl Physiol. 1978;44:703-709. (Pubitemid 9159921)
28. Scharf SM, Brown R, Saunders N, Green LH. Effects of normal and loaded spontaneous inspiration on cardiovascular function. J Appl Physiol. 1979;47:582-590. (Pubitemid 10222262)
29. Buda AJ, Pinsky MR, Ingels NB Jr, Daughters GT 2nd, Stinson EB, Alderman EL. Effect of intrathoracic pressure on left ventricular performance. N Engl J Med. 1979;301:453-459. (Pubitemid 10219948)
30. Takata M, Mitzner W, Robotham JL. Infuence of the pericardium on ventricular loading during respiration. J Appl Physiol. 1990;68:1640-1650. (Pubitemid 20151893)
31. Fessler HE, Permutt S. The thorax. In: Roussos C, ed. Lung Biology in Health and Disease. 2nd ed. New York: M. Dekker; 1995:1621-1640.
32. Oparil S. Pathogenesis of ventricular hypertrophy. J Am Coll Cardiol. 1985;5(suppl):57B-65B. (Pubitemid 15063742)
33. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, Greenland P, Jacob DR Jr, Kronmal R, Liu K, Nelson JC, O'Leary D, Saad MF, Shea S, Szklo M, Tracy RP. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol. 2002;156:871-881. (Pubitemid 35215769)
34. Mesia-Vela S, Yeh CC, Austin JH, Dounel M, Powell CA, Reeves A, Santella RM, Stevenson L, Yankelevitz D, Barr RG. Plasma carbonyls do not correlate with lung function or computed tomography measures of lung density in older smokers. Biomarkers. 2008;13:422-434. (Pubitemid 351865817)
35. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson D, Macintyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26:511-522. (Pubitemid 41264217)
36. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005;26:319-338. (Pubitemid 41079078)
37. Hankinson JL, Kawut SM, Shahar E, Smith LJ, Stukovsky KH, Barr RG. Performance of American Thoracic Society-recommended spirometry reference values in a multiethnic sample of adults: the Multi-Ethnic Study of Atherosclerosis (MESA) lung study. Chest. 2010;137:138-145.
38. Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932-946. (Pubitemid 38807371)
39. Young AA, Cowan BR, Thrupp SF, Hedley WJ, Dell'Italia LJ. Left ventricular mass and volume: fast calculation with guide-point modeling on MR images. Radiology. 2000;216:597-602. (Pubitemid 30599888)
40. Kawut SM, Barr RG, Lima JA, Praestgaard A, Johnson WC, Chahal H, Ogunyankin KO, Bristow MR, Kizer JR, Tandri H, Bluemke DA. Right ventricular structure is associated with the risk of heart failure and cardiovascular death: the Multi-Ethnic Study of Atherosclerosis (MESA)-right ventricle study. Circulation. 2012;126:1681-1688.
41. Gevenois PA, de Maertelaer V, De Vuyst P, Zanen J, Yernault JC. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med. 1995;152:653-657.
42. MESA-NHLBI. Exam 5 Field Center Procedures Manual of Operations. 2010. http://www.mesa-nhlbi.org/publicdocs/2011/mesae5-mopjanu-ary2011.pdf. Accessed April 26, 2012.
43. Psaty BM, Lee M, Savage PJ, Rutan GH, German PS, Lyles M. Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study: the Cardiovascular Health Study Collaborative Research Group. J Clin Epidemiol. 1992;45:683-692.
44. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
45. Brumback LC, Kronmal R, Heckbert SR, Ni H, Hundley WG, Lima JA, Bluemke DA. Body size adjustments for left ventricular mass by cardiovascular magnetic resonance and their impact on left ventricular hypertrophy classifcation. Int J Cardiovasc Imaging. 2010;26:459-468.
46. Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA, Jiang R, Kawut SM, Kronmal RA, Lima JA, Shahar E, Smith LJ, Watson KE. Percent emphysema, airfow obstruction, and impaired left ventricular flling. N Engl J Med. 2010;362:217-227.
47. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics. 1988;44:1049-1060. (Pubitemid 19026037)
48. Centers for Disease Control and Prevention. The Third National Health and Nutrition Examination Survey (NHANES III 1988-94) Reference Manuals and Reports (Materials on CD-ROM). Bethesda, MD: National Center for Health Statistics 1996.
49. Bilchick KC, Stukenborg GJ, Kamath S, Cheng A. Prediction of mortality in clinical practice for Medicare patients undergoing defbrillator implantation for primary prevention of sudden cardiac death. J Am Coll Cardiol. 2012;60:1647-1655.
50. Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest. 2005;128:2068-2075. (Pubitemid 41507542)
51. Zile MR, Gottdiener JS, Hetzel SJ, McMurray JJ, Komajda M, McKelvie R, Baicu CF, Massie BM, Carson PE; I-PRESERVE Investigators. Prevalence and signifcance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation. 2011;124:2491-2501.
52. MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease, part two. Am J Respir Crit Care Med. 1994;150:1158-1168.
53. Watz H, Waschki B, Meyer T, Kretschmar G, Kirsten A, Claussen M, Magnussen H. Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinfation. Chest. 2010;138:32-38.
54. Petty TL, Silvers GW, Stanford RE. Mild emphysema is associated with reduced elastic recoil and increased lung size but not with air-fow limitation. Am Rev Respir Dis. 1987;136:867-871. (Pubitemid 18028610)
55. Yip CK, Epstein H, Goldring RM. Relationship of functional residual capacity to static pulmonary mechanics in chronic obstructive pulmonary disease. Am J Med. Sci. 1984;287:3-6. (Pubitemid 14088378)
56. O'Donnell DE, Laveneziana P. The clinical importance of dynamic lung hyperinfation in COPD. COPD. 2006;3:219-232. (Pubitemid 44949062)
57. Dykstra BJ, Scanlon PD, Kester MM, Beck KC, Enright PL. Lung volumes in 4, 774 patients with obstructive lung disease. Chest. 1999;115:68-74. (Pubitemid 29047055)
58. Martin RJ, Pennock BE, Orr WC, Sanders MH, Rogers RM. Respiratory mechanics and timing during sleep in occlusive sleep apnea. J Appl Physiol. 1980;48:432-437. (Pubitemid 10141896)
59. Hedner J, Ejnell H, Caidahl K. Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. J Hypertens. 1990;8:941-946. (Pubitemid 20368617)
60. Onal E, Leech JA, Lopata M. Relationship between pulmonary function and sleep-induced respiratory abnormalities. Chest. 1985;87:437-441. (Pubitemid 15083478)